VOO and IVV charge the same fee and track the same index, yet the plumbing underneath each fund runs on completely different mechanics that can quietly favor one type of investor over another.
Confirming your doctor takes Medicare feels like due diligence, but that one phone call answers a completely different question than the one you need answered before picking an Advantage plan in October.
Sixth S-1 amendment fixes the IPO price at $4 for a $15 million Nasdaq raise
Veri MedTech's sixth amendment locks the price at a flat $4 for 3.75 million shares, a $15 million raise with Network 1 Financial Securities running the book. A fixed price rather than a range usually means the deal is close to done, so the Nasdaq debut is the next thing to look for.
Source: SEC filing
That forgotten 401(k) from your old job carries hidden traps that can cost you thousands before you even pick a single investment, and the rollover decision is far more consequential than most people realize.
MFB Bancorp files S-1 for a $9 million OTCQX debut at a fixed $10
A community bank conversion priced flat at $10 a share, with all 900,000 shares aimed at raising $9 million on OTCQX rather than a major exchange. Performance Trust Capital Partners is running the deal, the kind of thrift-style offering that rarely shows up on screeners until it is already trading.
Source: SEC filingSponsors are rushing to launch robot-themed ETFs at a pace not seen in years, betting billions on humanoid factories that do not yet exist. The funds already trading tell a very different story about who is actually winning.
SCHD’s 0.06% expense ratio gets all the attention, but something that happened quietly in March may have cost dividend investors far more than a decade of fees combined.
A couple, both 63, sitting on $1.5 million in traditional 401(k) assets, writing a voluntary check to the IRS for $60,000. On paper it looks like tax malpractice. In practice, it may be the highest-return decision they will make between now and Medicare enrollment. The scenario…
A loss where analysts modeled a profit, with adjusted EBITDA margin compressed to 18.2% from 23.3%. Management says same-store sales have improved into the third quarter.
Zscaler finished Monday up 16.8% at $192.17 while Coherent shed 12.5%. Four of the top five gainers are cybersecurity names, and four of the five losers are chip and infrastructure plays.
Ninth S-1/A keeps $4-$6 range intact ahead of Nasdaq listing
A ninth amendment means Little West is still grinding toward a Nasdaq debut, holding its terms at 3.75 million shares priced between $4 and $6 for about $18.75 million in gross proceeds. Benchmark is the sole underwriter on a micro-cap deal that will trade thin from day one.
Source: SEC filingThe S&P 500 gave up 35 points to close at 7,621.54, twice the drag seen in the Dow and Nasdaq. Rate-hike odds for this month are the live variable now that global banks have shifted to a tightening call.
